Table 2.

Incidence trends of lymphoid neoplasms diagnosed in Spain, 2002-2013.

Subtype	APC (%)	95% CI
Lymphoid neoplasm, total	0.3	(-0.1, 0.6)
1) Hodgkin lymphoma	1.1	(0.1, 2.1)	*
1.1 Classical Hodgkin lymphoma	0,7	(-0.3, 1.8)
1.2 Hodgkin lymphoma, nodular lymphocyte predominant	6.9	(2.5, 11.5)	*
Non-Hodgkin lymphoma	0.2	(-0.2, 0.5)
2) Precursor lymphoid neoplasms	-2,0	(-3.5, -0.5)	*
2.1 B-lymphoblastic leukemia/lymphoma	4,0	(1.2, 6.8)	*
2.2 T-lymphoblastic leukemia/lymphoma	5.2	(1.2, 9.4)	*
2.3 Lymphoblastic leukemia/lymphoma	-7,5	(-9.4, -5.5)	*
3) Mature B-cell neoplasms	0.6	(0.3, 1.0)	*
3.1 Chronic lymphocytic leukemia/small lymphocytic lymphoma	-2,2	(-3.0, -1.5)	*
3.2 B-cell prolymphocytic leukemia	5.7	(-5.6, 18.4)
3.3 Hairy cell leukemia	-0,8	(-4.4, 2.9)
3.4 Marginal zone lymphoma	2,9	(1.5, 4.2)	*
3.5 Lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia	1.0	(-1.0, 3.1)
3.6 Plasma cell myeloma/leukemia	0.1	(-0.6, 0.8)
3.7 Follicular lymphoma	4.0	(3.1, 5.0)	*
3.8 Mantle cell lymphoma	-0,7	(-2.7, 1.3)
3.9 Diffuse large B-cell lymphoma	1.2	(0.5, 2.0)	*
3.10 Burkitt lymphoma/leukemia	-0,8	(-3.7, 2.1)
3.11 Composite Hodgkin and non-Hodgkin lymphoma	44.3	(17.6, 77.1)	*
4) Mature-T-cell and NK-cell neoplasms	1.3	(0.0, 2.6)
4.1 Mycosis fungoides/Sézary syndrome	-0,4	(-2.5, 1.7)
4.2 Other peripheral T- cell and NK-cell lymphoma	2,3	(0.7, 3.9)	*
5) Lymphoid neoplasms, NOS	-5,6	(-6.8, -4.3)	*

Bold values highlight the main subtypes and its data.

* p-value < 0.05.